Dong-A ST unveils clinical trial results for its diabetes treatment

Dong-A ST has released the results of EVERGREEN, a clinical trial for Suganon (evogliptin), a dipeptidyl peptidase 4 (DPP-4) inhibitor. The drug’s advantage is that patients can take it regardless of meals. Also, the small size of the tablets compared to http://www.koreabiomed.com/news/articleView.html?idxno=4649